Tissue repair by thrombin-derived peptides in the rat

Area of Science:

• Biochemistry
• Wound Healing Research
• Peptide Therapeutics

Background:

• Tissue damage triggers a complex healing cascade.
• Thrombin is a key molecule involved in the wound healing process.
• Thrombin-derived peptides containing the RGD motif are being investigated for therapeutic potential.

Purpose of the Study:

• To evaluate the efficacy of two thrombin-derived peptides, p517 and p508, in promoting tissue repair.
• To assess peptide performance in both normal and healing-impaired (glucocorticoid-stressed) rat models.
• To investigate the dose-dependent effects and application timing of these peptides.

Main Methods:

• Utilized linear incision and full dermal excision wound models in rats.
• Administered varying doses of p508 and p517 peptides post-surgery.
• Assessed wound healing by measuring wound strength and wound area.
• Included glucocorticoid administration to create healing-impaired conditions.

Main Results:

• Peptide p508 significantly improved wound strength in a dose-dependent manner (0.23% increase at 0.5 µg/wound).
• Peptide p517 significantly increased linear incision wound-breaking strength by approximately 18% at 9 days post-surgery.
• Neither peptide significantly improved healing in glucocorticoid-stressed rats.
• Peptide p508 significantly reduced wound area in glucocorticoid-impaired excision models at days 3 and 5.

Conclusions:

• Thrombin-derived peptides p508 and p517 demonstrate potential to enhance wound healing and strength.
• The therapeutic benefits may involve activation of fibroblast proliferation or other cell signaling via RGD-mediated interactions.
• Further research is needed to optimize application and overcome impairment in healing.